Technical Analysis for WDNA - WisdomTree BioRevolution Fund
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 16.25 | 0.12% | 0.02 |
WDNA closed up 2.4 percent on Friday, May 3, 2024, on 37 percent of normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline. It ran into resistance at its 50 day moving average. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Flat | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
50 DMA Resistance | Bearish | 0.12% | |
Crossed Above 200 DMA | Bullish | 0.12% | |
Cup with Handle | Other | 0.12% | |
Narrow Range Bar | Range Contraction | 0.12% | |
Stochastic Reached Overbought | Strength | 0.12% | |
Gapped Up | Strength | 0.12% | |
Overbought Stochastic | Strength | 0.12% | |
Up 3 Days in a Row | Strength | 0.12% | |
Crossed Above 20 DMA | Bullish | 2.52% | |
Cup with Handle | Other | 2.52% |
Alert | Time |
---|---|
Gap Up Partially Closed | about 5 hours ago |
Gapped Up (Partial) | about 6 hours ago |
Rose Above Previous Day's High | about 6 hours ago |
50 DMA Resistance | about 6 hours ago |
2x Volume Pace | about 6 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
The investment seeks to track the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution Index (?index?). The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the Index as a whole. The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. The fund is non-diversified.
Classification
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 18.3725 |
52 Week Low | 13.2624 |
Average Volume | 1,347 |
200-Day Moving Average | 16.06 |
50-Day Moving Average | 16.32 |
20-Day Moving Average | 15.70 |
10-Day Moving Average | 15.54 |
Average True Range | 0.28 |
RSI (14) | 56.33 |
ADX | 22.15 |
+DI | 47.91 |
-DI | 30.71 |
Chandelier Exit (Long, 3 ATRs) | 15.97 |
Chandelier Exit (Short, 3 ATRs) | 15.93 |
Upper Bollinger Bands | 16.70 |
Lower Bollinger Band | 14.70 |
Percent B (%b) | 0.77 |
BandWidth | 12.74 |
MACD Line | -0.18 |
MACD Signal Line | -0.28 |
MACD Histogram | 0.1005 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 16.41 | ||||
Resistance 3 (R3) | 16.43 | 16.39 | 16.38 | ||
Resistance 2 (R2) | 16.39 | 16.35 | 16.38 | 16.37 | |
Resistance 1 (R1) | 16.31 | 16.32 | 16.29 | 16.29 | 16.36 |
Pivot Point | 16.27 | 16.27 | 16.26 | 16.26 | 16.27 |
Support 1 (S1) | 16.19 | 16.23 | 16.17 | 16.17 | 16.10 |
Support 2 (S2) | 16.15 | 16.20 | 16.14 | 16.09 | |
Support 3 (S3) | 16.07 | 16.15 | 16.08 | ||
Support 4 (S4) | 16.05 |